rs6092

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000602.5(SERPINE1):​c.43G>A​(p.Ala15Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 1,613,970 control chromosomes in the GnomAD database, including 9,254 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.081 ( 665 hom., cov: 32)
Exomes 𝑓: 0.11 ( 8589 hom. )

Consequence

SERPINE1
NM_000602.5 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1U:1B:8O:1

Conservation

PhyloP100: 0.344

Publications

92 publications found
Variant links:
Genes affected
SERPINE1 (HGNC:8583): (serpin family E member 1) This gene encodes a member of the serine proteinase inhibitor (serpin) superfamily. This member is the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), and hence is an inhibitor of fibrinolysis. The protein also functions as a component of innate antiviral immunity. Defects in this gene are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency), and high concentrations of the gene product are associated with thrombophilia. [provided by RefSeq, Aug 2020]
SERPINE1 Gene-Disease associations (from GenCC):
  • congenital plasminogen activator inhibitor type 1 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024650395).
BP6
Variant 7-101128436-G-A is Benign according to our data. Variant chr7-101128436-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 13573.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERPINE1NM_000602.5 linkc.43G>A p.Ala15Thr missense_variant Exon 2 of 9 ENST00000223095.5 NP_000593.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERPINE1ENST00000223095.5 linkc.43G>A p.Ala15Thr missense_variant Exon 2 of 9 1 NM_000602.5 ENSP00000223095.4

Frequencies

GnomAD3 genomes
AF:
0.0808
AC:
12283
AN:
152096
Hom.:
663
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0191
Gnomad AMI
AF:
0.177
Gnomad AMR
AF:
0.0710
Gnomad ASJ
AF:
0.118
Gnomad EAS
AF:
0.0871
Gnomad SAS
AF:
0.108
Gnomad FIN
AF:
0.0649
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.117
Gnomad OTH
AF:
0.0965
GnomAD2 exomes
AF:
0.0952
AC:
23897
AN:
251022
AF XY:
0.0991
show subpopulations
Gnomad AFR exome
AF:
0.0179
Gnomad AMR exome
AF:
0.0697
Gnomad ASJ exome
AF:
0.121
Gnomad EAS exome
AF:
0.0892
Gnomad FIN exome
AF:
0.0683
Gnomad NFE exome
AF:
0.113
Gnomad OTH exome
AF:
0.102
GnomAD4 exome
AF:
0.106
AC:
155622
AN:
1461756
Hom.:
8589
Cov.:
33
AF XY:
0.107
AC XY:
77992
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.0159
AC:
531
AN:
33478
American (AMR)
AF:
0.0702
AC:
3140
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.118
AC:
3090
AN:
26134
East Asian (EAS)
AF:
0.0794
AC:
3151
AN:
39700
South Asian (SAS)
AF:
0.110
AC:
9463
AN:
86258
European-Finnish (FIN)
AF:
0.0731
AC:
3898
AN:
53328
Middle Eastern (MID)
AF:
0.0943
AC:
544
AN:
5768
European-Non Finnish (NFE)
AF:
0.113
AC:
125717
AN:
1111980
Other (OTH)
AF:
0.101
AC:
6088
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
8235
16470
24706
32941
41176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4532
9064
13596
18128
22660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0807
AC:
12285
AN:
152214
Hom.:
665
Cov.:
32
AF XY:
0.0792
AC XY:
5894
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0191
AC:
792
AN:
41542
American (AMR)
AF:
0.0708
AC:
1082
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.118
AC:
409
AN:
3472
East Asian (EAS)
AF:
0.0873
AC:
452
AN:
5180
South Asian (SAS)
AF:
0.108
AC:
523
AN:
4822
European-Finnish (FIN)
AF:
0.0649
AC:
688
AN:
10598
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.117
AC:
7937
AN:
68002
Other (OTH)
AF:
0.0997
AC:
211
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
584
1169
1753
2338
2922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
1528
Bravo
AF:
0.0775
TwinsUK
AF:
0.113
AC:
418
ALSPAC
AF:
0.117
AC:
450
ESP6500AA
AF:
0.0229
AC:
101
ESP6500EA
AF:
0.117
AC:
1008
ExAC
AF:
0.0963
AC:
11693
Asia WGS
AF:
0.111
AC:
387
AN:
3478
EpiCase
AF:
0.118
EpiControl
AF:
0.114

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Uncertain:1Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Congenital plasminogen activator inhibitor type 1 deficiency Pathogenic:1Benign:3Other:1
-
ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:research

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jan 01, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Apr 17, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 12, 2023
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process Uncertain:1
Jun 29, 2021
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

Differences in coagulation-related proteins according to the genotype of patients with severe COVID-19 -

SERPINE1-related disorder Benign:1
Aug 18, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 12856128, 20981092, 15182577, 15650551) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.12
FATHMM_MKL
Benign
0.65
D
LIST_S2
Benign
0.77
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.4
L
PhyloP100
0.34
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.30
N
REVEL
Uncertain
0.36
Sift
Benign
0.29
T
Sift4G
Benign
0.56
T
Polyphen
0.28
B
Vest4
0.023
MPC
0.22
ClinPred
0.022
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.056
gMVP
0.38
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6092; hg19: chr7-100771717; COSMIC: COSV56170554; API